Objective: To study the association between Electronic Health Record (EHR)/Computerized Physician Order Entry (CPOE) provider price display, and domains of healthcare quality (efficiency, effective care, patient centered care, patient safety, equitable care, and timeliness of care). Methods: Randomized and non-randomized studies assessing the relationship between healthcare quality domains and EHR/CPOE provider price display published between 1/1/1980 to 2/1/2018 were included. MED-LINE, Web of Science, and Embase were searched. Assessment of internal validity of the included studies was performed with a modified Downs-Black checklist. Results: Screening of 1118 abstracts was performed resulting in selection of 41 manuscripts for full length review. A total of 13 studies were included in the final analysis. Thirteen studies reported on efficiency domain, one on effectiveness and one on patient safety. Studies assessing relationship between provider price display and patient centered, equitable and timely care domains were not retrieved. Quality of the studies varied widely (Range 6-12 out of a maximum possible score of 13). Provider price display in electronic health record environment did not consistently influence domains of healthcare quality such as efficiency, effectiveness and patient safety. Conclusions: Published evidence suggests that price display tools aimed at ordering providers in EHR/CPOE do not influence the efficiency domain of healthcare quality. Scant published evidence suggests that they do not influence the effectiveness and patient safety domains of healthcare quality. Future studies are needed to assess the relationship between provider price display and unexplored domains of healthcare quality (patient centered, equitable, and timely care). Registration: PROSPERO registration: CRD42018082227
INTRODUCTION
Physician price awareness is a recognized knowledge gap.
1,2 Lack of price awareness has been associated with increased resource utilization 3 contributing to reduced efficiency, a healthcare quality domain. 4 Price awareness has the potential to help providers and patients efficiently use healthcare dollars.
Use of physician education and feedback as strategies to increase price awareness have however yielded equivocal cost containment results. 5 Price display tools as a price awareness strategy have been hypothesized to reduce inefficiency by improving knowledge about costs 6, 7 thereby changing ordering behavior. Price display on paper in the non-electronic health record era was associated with reduced costs. 8, 9 Coinciding with the introduction of electronic health records (years 1990-2000) and the diffusion of EHR adoption (years [2000] [2001] [2002] [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] [2013] [2014] [2015] , various authors [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] studied the impact of price display during computerized physician order entry on domains of healthcare quality such as efficiency, effectiveness, and safety. These studies differed in the setting, and design, as well as their conclusions. Previous systematic reviews studying the relationship between price display and costs concluded that price display is associated with improved efficiency (ie reduced costs of care) without impacting patient safety. 27, 28 However, these reviews combined price display studies done in the electronic and non-electronic health record environments (ie paper display of price) in their analyses. Information processing and retention differs by mode of display (ie learning from paper display is better than from an electronic display, termed as "screen inferiority"). 29, 30 Learning from text characters under time pressure, a factor common to EHR order entry, is known to be less effective on an electronic screen when compared with paper. 31 That is why studies of price display in the paper era are likely not applicable to the current electronic health record era. A systematic review focused on provider price display in the electronic health record during computerized physician order entry was undertaken to study the relationship between price display and the domains of healthcare quality 4 (efficiency [costs] , effectiveness, patient safety, timely care, patient centered, and equitable care). Medical subject headings (MeSH) corresponding to these terms were used in MEDLINE searches and keywords as described above were used in other databases during the search execution. A Boolean strategy was employed to form an association between these terms in the final phase of search execution. An example of a search execution is provided in Figure 1 . PRISMA 32 checklist is supplied as Supplementary Appendix 3.
METHODS

Data sources and search
In addition, a "pearl-growing" 33 strategy was employed using the references section of well-cited reviews and the search results. They were included to be analyzed in the full review phase of the study. Approval from the Institutional Review Board was unnecessary, because this was a systematic review of published literature and did not involve human subjects.
Study selection
Inclusion and exclusion criteria were framed prior to the implementation of the search strategy and registered with an international prospective register of systematic reviews -PROSPERO (https:// www.crd.york.ac.uk/prospero/display_record.php? RecordID¼82227; #CRD42018082227). 34 To evaluate the effect of price display in computerized physician order entry (CPOE) on healthcare quality, we included studies based on the following PICO (T) criteria:
1. Population: Physicians requesting or patients receiving care orders (laboratory, imaging, pharmacy and procedural) through computerized physician order entry. 2. Intervention: Group that was exposed to price display tools during laboratory, imaging, procedural and pharmaceutical orders in CPOE. 3. Comparator/Control: Concurrent or historical group that received care orders through CPOE and usual workflow of the ordering provider without price display. 4. Outcomes: Healthcare quality domains as defined by the National Academy of Medicine's (previously known as Institute of Medicine) definition of healthcare quality 4 (efficiency measured by costs or total number of orders, effectiveness measured by number of appropriate or inappropriate orders, patient safety/ harm, patient centered care markers, timely care). 5. Timing and effect measures: Price display intervention performed for 6 months.
Non-English publications, case reports, studies with additional co-interventions during the study period (eg price display accompanied by radiation dose display, price display accompanied by introduction of computerized physician order entry system), studies without a historical or concurrent control group, and studies with price display intervention less than 6 months were excluded. An internet-based product/platform (Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia) was used for electronic importing of search results from the databases. Covidence performed automatic exclusion of duplicates during the process of importing results from diverse databases. Two authors [SM, RM] performed independent screening of titles and abstracts for full text screening by logging into their Covidence account. A record of votes resulting in "irrelevant," "full text screening" and "disagreement" categories was generated by Covidence software. Disagreements were resolved by direct communication.
Data extraction and outcome measures
One author (SM) extracted and rated the data from the selected fulllength articles using a standardized form. From each study, the data abstracted included study name/year, setting, study design (prospective controlled, randomized controlled trial, retrospective etc.), type of computerized physician order entry (CPOE [imaging vs laboratory vs procedures etc.]), population, intervention group(s), design of the price display intervention, comparator group(s), outcomes, and the results.
The National Academy of Medicine's definition of healthcare quality 4 was used to categorize the domain (efficiency, effectiveness, timely care, patient centered care, equitable and safe care) of the reported outcomes. For example, a study assessing whether price display in CPOE resulted in lower charges to the patient would have been categorized into the efficiency domain of healthcare quality. If a study assessed whether price display in CPOE resulted in increased patient satisfaction due to less number of invasive specimen acquisitions, it would have been categorized into the domain of patient centered care. While extracting data from the full text articles, study results pertaining to overall analyses were prioritized over subgroup analyses. Results from exploratory analyses were not considered. Weighted and adjusted analyses were given priority over unweighted and unadjusted analyses.
Quality assessment criteria
Studies that met inclusion criteria were evaluated for risk of bias using components of the modified Downs Black 35 checklist. Thirteen questions pertaining to the internal validity (bias and confounding) sections of the original Downs Black checklist 35 were used in our quality assessment. The maximum possible score was 13. The modified Downs Black checklist with individual scoring for each study is supplied in the Supplementary Appendix 1.
RESULTS
The initial search identified 1118 possible studies. These titles and abstracts were assessed independently by two reviewers with fair interrater reliability (Cohen's j ¼ 0.33). 36 After consensus was reached, 41 studies were selected for full text review, and the complete articles were independently assessed by two authors (SM, RM). Using the inclusion and exclusion criteria, 34 studies were excluded with moderate interrater reliability (Cohen's j ¼ 0.53). 36 A total of 7 studies entered the preliminary inclusion pool. Another 6 studies were added from those identified by pearling reference lists for a total of 13 studies [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] 26 for the final analysis. The results con- 17 The sequence describing the above process can be found in Figure 2 . All 13 studies examined the relationship between price display and the efficiency domain of healthcare quality. One study 20 additionally assessed the relationship between price display and effectiveness domain of healthcare quality. Another study 10 assessed the relationship between price display and safety domain of healthcare quality. None of the included studies assessed the relationship between price display and patient centered care, timely, or equitable care.
The quality or risk of bias assessments of the included studies varied widely and are reported in Table 1 
Impact on efficiency domain
Results based on data extraction are presented in Table 2 . Out of the 13 included studies, 10 did not find a relationship between price display and cost of care, while 3 reported that price display was associated with cost savings. More recent randomized controlled trials (2016 and 2017) did not find any relationship between efficiency and provider price display. All 4 studies done in the community setting where physicians who completed graduate training practiced did not show any relationship between cost savings and price display. 11, 14, 18, 20 Similarly, the 6 studies done in inpatient and outpatient settings of teaching hospitals did not find any cost savings with price display. 12, 13, 16, 19, 21, 26 Two randomized controlled trials, 1 done in an inpatient 15 and 1 in an outpatient setting 10 of teaching hospitals showed cost savings with price display. One prospective non-randomized study restricted to reference laboratory tests (ie tests sent to an outside laboratory) showed significant cost savings. 17 
Impact on other domains
The only study that studied effectiveness in relation to price display concluded that effectiveness did not improve with price display. 20 Results are displayed in Table 3 . A study that additionally examined patient safety and price display did not find a relationship between the two. 10 As mentioned above, studies assessing the relationship between price display and patient centered care, timely, or equitable care domains were not found in our search results. Due to the heterogeneity of the study designs, interventions and outcomes, a meta-analysis was not feasible. Additional quantitative details of significant and non-significant findings in each study are presented in the Supplementary Appendix 2.
DISCUSSION
Many experts believe introduction of price display in the electronic health record (EHR) during computerized physician order entry (CPOE) is quick to implement and easy to maintain. Therefore, price display was hypothesized to be a feasible and powerful weapon in reducing costs of care. However, this review, concludes that provider price display in the EHR does not consistently reduce the costs of care related to laboratory, imaging, procedural orders across setting (ie outpatient, inpatient, community, and teaching hospitals).
This conclusion is in direct contrast to the findings of the previous systematic reviews in this field. 27, 28 Our review differs from the previous reviews in that it includes 4 additional high quality randomized controlled trials that involved >140 000 patient days in each study. 18, 20, 21, 26 This review excluded studies done using price display on paper 8,9,37 which have usually shown significant cost savings and were included in previous reviews. This exclusion is an important departure from existing reviews as comprehension and learning especially under time constraints differ in paper and electronic screen environments (ie electronic screen based learning is inferior, termed as screen inferiority). [29] [30] [31] Potential explanations for provider price display in EHRs not working to reduce costs of care include screen inferiority, 29 reduced visibility of non-intrusive price display, 26 price display not accessible to patients, perceived need of a diagnostic test that overrides cost concerns, and price awareness not being complete information about true costs of care. Two studies 18, 20 incorporated prices that were close to real costs of a diagnostic test and found no cost savings associated with display of such information. In some cases, price display tools can lead to increased utilization of diagnostic tests. Sedrak et al. 21 found a relative modest increase (2%) in tests performed per patient day in the group randomized to price display. Likewise, Chien et al. 18 found increased resource utilization in adult subspecialists taking care of children when exposed to price display in a randomized fashion. This phenomenon can be explained by a tendency to order tests when the displayed price is much less than the expected price. Such unintended consequences must be kept in mind before routine EHR price display is advocated for 38 despite lack of efficacy based on the "no benefit, no harm" principle. Access to price information for patients in contrast to provider price display has the potential for significant cost reductions as evidenced by results from 2 recent studies that focused on patient price awareness. 39, 40 An important distinction needs to be made between the types of orders (laboratory, imaging, procedural orders) studied. It is likely that characteristics of diagnostic tests and ordering circumstances influence whether they have the potential for reduction in utilization. For example, inpatient imaging tests are not usually ordered daily except for the chest x ray in the intensive care unit. 16 It is plausible to assume imaging orders are ordered based on a new clinical event. Therefore, it is likely that none of the studies that analyzed imaging orders and price display have shown any significant cost savings as a changing clinical context overrides cost concerns. Laboratory tests, however, are usually drawn daily because of the typical design of an institutional or provider's customized EHR admission order set executed on the day of admission. Design factors such as pre-checked daily laboratory orders (eg "complete blood count Q AM") result in default daily laboratory draws and potential loss of price display opportunities. Such loss of multiple price visualization opportunities could have impacted any benefits of price display especially in the inpatient studies. While price display did not result in consistent reduction in laboratory test utilization, other equally simple design-based interventions, such as eliminating default daily laboratory draw frequencies in EHR, resulted in significant reduction. 24, 41, 42 Eliminating default daily laboratory orders is a particularly promising intervention as the prevalence of patients receiving admission day orders for daily recurring laboratory tests has been reported to be as high as 95% in a large urban teaching hospital. 42 An argument can be made about improving the design of existing passive price display tools to create interactive second-generation price display tools based on sophisticated clinical decision support architecture. However, improving the design of a price display tool by adding more visible information and creating the need for additional provider-computer interaction has potential negative consequences such as physician dissatisfaction (increased time spent in CPOE) and increased investment required to design and maintain these tools. When pursued, the design of these interactive second- Blinding study subjects (providers) to the intervention was not possible in any study due to the nature of intervention.
b Randomized controlled trial. generation tools should incorporate accepted best practices 43 to assure potential real-life effectiveness. While it is accepted that gaps exist in physician price awareness, it is likely that no one single intervention aimed at improving physician price awareness will get us to the promised land of cost containment. Current evidence suggest that bundled sets of interventions based on redesign of electronic health record order(s)/order set(s) eliminating routine daily inpatient ordering, provider and patient education, patient price awareness, 39, 40 audit and feedback are likely the best possible route to cost containment. 5 Our review has limitations. We were not able to perform a quantitative assessment of our findings due to significant heterogeneity in the included studies. Results were restricted to the English language, and we were unable to obtain any unpublished studies. However, due to the consistent, negative results in the included studies, the effect of a potential publication bias is likely to be negligible. Strengths include a robust search strategy and comprehensive a priori inclusion and exclusion criteria.
CONCLUSION
Published evidence suggests that price display tools aimed at ordering providers in EHR/CPOE do not influence the efficiency domain of healthcare quality. Scant published evidence suggests that they do not influence the effectiveness and patient safety domains of healthcare quality. Future studies are needed to assess the relationship between provider price display and unexplored domains of healthcare quality (patient centered, equitable, and timely care).
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